Literature DB >> 28477259

Measuring hemoglobin prior to early discharge without routine surveillance ultrasound after percutaneous native renal biopsy in children.

Prakash Muthusami1, Sunit Sunder2, Claire Gallibois3, Evan Kitamura2, Dimitri Parra2, Joao Amaral2, Phillip John2, Damien Noone3, Bairbre Connolly2.   

Abstract

BACKGROUND: We aimed to evaluate the role of post-procedural hemoglobin (hb), without pre-discharge ultrasound (US), after US-guided renal biopsy in children.
METHODS: A retrospective review was conducted of consecutive outpatient native kidney biopsies over an 8-year period. Procedures were performed under real-time US guidance. Data collected included number of passes, presence and size of perinephric hematoma, age, body mass index (BMI), blood pressure (BP), fasting status, hb and platelets. Continuous variables were expressed as mean ± standard deviation, group differences were tested with Student's unpaired t test and analysis of variance and correlations were assessed using Pearson's r. Significance was defined as p < 0.05. Hb changes (g/L), percentage hb (%hb) change, hematoma size and positive and negative predictive values (PPV, NPV, respectively) were analyzed.
RESULTS: A total of 330 procedures in 300 children (141 females, mean age 11.2 ± 4.30 years) were analyzed. Post-procedural hematoma occurred in 63%. There was a significant (p = 0.0001) post-procedural hb decrease of 6.3 ± 5.5 g/L and %hb decrease of 4.56 ± 4.01%. Fasting during pre-procedural hb estimation and procedural hematoma was associated with a greater hb drop. A ≥10% hb drop had 73% PPV for repeat blood work and US and a 17% PPV for admission, whereas a <10% hb drop had a NPV of 84% and 98%, respectively. Hb change showed a weak correlation with age, and hematoma size showed a weak inverse correlation with platelet count, but no correlation with BMI, number of passes or BP.
CONCLUSIONS: Bleeding complications from US-guided native kidney biopsies in pediatric outpatients can be safely followed by a complete blood count at 6 h post procedure. A 10% hb decrease is strongly associated with requirement for further testing and/or admission.

Entities:  

Keywords:  Children; Hematoma; Hemoglobin; Nephrotic syndrome; Renal biopsy; Ultrasound

Mesh:

Substances:

Year:  2017        PMID: 28477259     DOI: 10.1007/s00467-017-3680-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  Renal biopsy: Still a landmark for the nephrologist.

Authors:  Luca Visconti; Valeria Cernaro; Carlo Alberto Ricciardi; Viviana Lacava; Vincenzo Pellicanò; Antonio Lacquaniti; Michele Buemi; Domenico Santoro
Journal:  World J Nephrol       Date:  2016-07-06

3.  Development of an outpatient native kidney biopsy service in low-risk patients: a multidisciplinary approach.

Authors:  Gearoid M McMahon; Molly E McGovern; Vanesa Bijol; Carol B Benson; Richard Foley; Karen Munkley; Jeffrey Schnipper; Calvin Franz; Julie Lin
Journal:  Am J Nephrol       Date:  2012-03-24       Impact factor: 3.754

4.  Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis.

Authors:  Pornpimol Rianthavorn; Athitaya Buddhasri
Journal:  Pediatr Nephrol       Date:  2015-06-09       Impact factor: 3.714

5.  A Randomised Clinical Trial to Compare Coaxial and Noncoaxial Techniques in Percutaneous Core Needle Biopsy of Renal Parenchyma.

Authors:  Ali Babaei Jandaghi; Mohammadkazem Lebady; Athar-Alsadat Zamani; Abtin Heidarzadeh; Ali Monfared; Ramin Pourghorban
Journal:  Cardiovasc Intervent Radiol       Date:  2016-09-30       Impact factor: 2.740

6.  Risk management of renal biopsy: 1387 cases over 30 years in a single centre.

Authors:  P Stratta; C Canavese; M Marengo; P Mesiano; L Besso; M Quaglia; D Bergamo; G Monga; G Mazzucco; G Ciccone
Journal:  Eur J Clin Invest       Date:  2007-12       Impact factor: 4.686

7.  Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010.

Authors:  Camilla Tøndel; Bjørn Egil Vikse; Leif Bostad; Einar Svarstad
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-26       Impact factor: 8.237

8.  Ten-year review of disease pattern from percutaneous renal biopsy: an experience from a paediatric tertiary renal centre in Hong Kong.

Authors:  L K Yuen; W M Lai; S C Lau; P C Tong; K C Tse; M C Chiu
Journal:  Hong Kong Med J       Date:  2008-10       Impact factor: 2.227

9.  Percutaneous renal biopsy: outpatient observation without hospitalization is safe.

Authors:  Ivan D Maya; Michael Allon
Journal:  Semin Dial       Date:  2009-05-15       Impact factor: 3.455

10.  Timing of complications in percutaneous renal biopsy.

Authors:  William L Whittier; Stephen M Korbet
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

View more
  2 in total

1.  Kidney biopsy guidebook 2020 in Japan.

Authors:  Yoshifumi Ubara; Takehiko Kawaguchi; Tasuku Nagasawa; Kenichiro Miura; Takayuki Katsuno; Takashi Morikawa; Eiji Ishikawa; Masao Ogura; Hideki Matsumura; Ryota Kurayama; Shinsuke Matsumoto; Yuhji Marui; Shigeo Hara; Shoichi Maruyama; Ichiei Narita; Hirokazu Okada; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2021-04       Impact factor: 2.801

2.  Frequency, Timing, and Prediction of Major Bleeding Complications From Percutaneous Renal Biopsy.

Authors:  Melissa Schorr; Pavel S Roshanov; Matthew A Weir; Andrew A House
Journal:  Can J Kidney Health Dis       Date:  2020-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.